Facile synthesis of C-terminal peptide thioacids under mild conditions from N-sulfanylethylanilide peptides by Shimizu, Tatsuhiko et al.
0 
Graphical Abstract  
To create your abstract, type over the instructions in the template box below. 
Fonts or abstract dimensions should not be changed or altered. 
Facile synthesis of C-terminal peptide 
thioacids under mild conditions from N-
sulfanylethylanilide peptides 
Tatsuhiko Shimizu, Rin Miyajima, Kohei Sato, Ken Sakamoto, Naoto Naruse, Miku Kita, Akira Shigenaga* and 
Akira Otaka* 
Institute of Biomedical Sciences and Graduate School of Pharmaceutical Sciences, Tokushima University, 
Tokushima 770-8505, Japan. 
Leave this area blank for abstract info. 
1 
Tetrahedron 
journal  homepage:  www.e lsevier .com  
Facile synthesis of C-terminal peptide thioacids under mild conditions from N-
sulfanylethylanilide peptides 
Tatsuhiko Shimizu, Rin Miyajima, Kohei Sato, Ken Sakamoto, Naoto Naruse, Miku Kita, Akira Shigenaga* 
and Akira Otaka*
Institute of Biomedical Sciences and Graduate School of Pharmaceutical Sciences, Tokushima University, Tokushima 770-8505, Japan. 
1. Introduction
Native chemical ligation (NCL) has shown great utility in
chemical protein synthesis.1,2 This methodology allows for the 
chemoselective condensation of a peptide thioester with an N-
terminal cysteinyl peptide via sequential S-S and S-N acyl 
transfer reactions to afford the corresponding ligated product 
under mild aqueous conditions. Therefore, auxiliary-based 
peptide thioester precursors that can be readily converted to the 
corresponding thioesters via N-S acyl transfer, as necessary, 
have recently been developed for the chemical synthesis of 
proteins.3,4 Several research groups, including our own, have 
reported that C-terminal peptide thioacids can be also used for 
protein synthesis.5,6 However, only a few synthetic methods 
have been developed to date for the preparation of C-terminal 
peptide thioacids. Furthermore, most of these methods involve 
the use of Boc-based solid phase peptide synthesis (Boc 
SPPS),6a-c,7 which requires the treatment with highly toxic 
hydrogen fluoride or some other harsh acid for the global 
deprotection of the peptide and its cleavage from the resin. Crich 
et al. recently reported a new method for the preparation of 
peptide thioacids using a 9-fluorenylmethyl thioester linker, 
which was compatible with Boc SPPS.8 Notably, this method 
did not require the use of hydrogen fluoride or any other harsh 
acid, and allowed for the release of the resulting peptide thioacid 
from the resin by piperidine treatment. Although this method 
provided an improved process for the global deprotection of the 
peptide product, it required several laborious steps for the 
preparation of the amino acid building blocks bearing 
specialized 9-fluorenylmethyl type side-chain protecting groups. 
In contrast, Fmoc-based solid-phase peptide synthesis (Fmoc 
SPPS) is used much more often for the synthesis of peptides 
because it is technically less challenging and requires milder 
reagents compared with Boc SPPS. Several research groups, 
including our own,5,7e,9 have therefore developed Fmoc SPPS-
compatible strategies for the preparation of peptide thioacids. In 
our previous study, we developed an N-sulfanylethylanilide 
(SEAlide) peptide as a peptide thioester precursor using standard 
Fmoc SPPS.4i This material was subsequently converted to a 
peptide thioacid via a hydrogen chloride-induced N-S acyl 
transfer reaction in the presence of 1% (w/v) tris(2-
carboxyethyl)phosphine hydrochloride (TCEP·HCl) followed by 
the hydrothiolysis of the resulting thioester with sodium 
hydrogen sulfide (NaSH) (Scheme 1).5a However, we observed 
the epimerization of the C-terminal amino thioacid residue 
during this reaction, which was attributed to the use of the strong 
acid hydrogen chloride. The development of an epimerization-
free SEAlide-based method is therefore highly desired for the 
practical application of this method. We recently discovered that 
the SEAlide peptide 1 shown in Scheme 2 could be equilibrated 
with the corresponding thioester under neutral conditions in the 
presence of phosphate. Furthermore, peptide 1 could be used 
directly in an NCL process without any epimerization at the 
ligation site.10,11 These results prompted us to use this 
equilibrium process to generate the peptide thioacid 2 from the 
SEAlide peptide 1 under mild conditions without the use of 
hydrogen chloride. Herein, we describe the development of an 
Fmoc SPPS-compatible method for the preparation of peptide 
thioacids using the SEAlide peptides. 
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Scheme 1. Previously reported Fmoc-based preparation of peptide thioacids 
using the SEAlide peptide.5a 
 
 
Scheme 2. Conversion of the SEAlide peptide to the corresponding thioacids 
under the mild conditions used in this study. 
 
2. Results and discussion 
The SEAlide peptides 6 were prepared using Fmoc SPPS 
according to the previously reported method (Scheme 3).12 N-
Terminal human RFamide-related peptide-1 (hRFRP-1) (1-11) 
was selected as a model peptide for this study.13 The conversion 
of SEAlide peptide 6a to thioacid 7a was initially attempted 
with 120 mM NaSH in phosphate buffer containing TCEP·HCl 
as an inhibitor of disulfide formation and sodium ascorbate as an 
alternative to thiol additive14 in the presence of 10% (v/v) N-
methylpyrrolidone (NMP) (Table 1). We initially evaluated the 
effect of the phosphate salt for confirmation of our hypothesis 
that the presence of phosphate is essential for the hydrothiolysis 
reaction. Results in Table 1 (entries 1–4) clearly showed that the 
yield of peptide thioacid 7a varied with the concentration of 
phosphate salt, indicating that the presence of phosphate was 
essential for the hydrothiolysis reaction. In the absence of NMP, 
we observed a subtle decrease in the product yield, which was 
attributed to the instability of the intermediate thioester in the 
absence of an organic solvent (Table 1, entries 4 and 5).15  
 
 
Scheme 3. Synthesis of SEAlide peptide 6a-h using Fmoc SPPS. 
 
We then proceeded to investigate the effect of the peptide 
concentration on the reaction (Table 1, entries 4, 6 and 7). The 
results of these experiments revealed that the increase in the 
concentration of peptide 6a, decreasing the equivalent of the 
hydrosulfide ion source, led to a decrease in the yield of the 
product. The pH also had a significant impact on the yield of the 
desired product, especially under acidic conditions (Table 1, 
entries 4, 8 and 9). We subsequently examined the effect of a 
hydrosulfide anion source to the reaction. The replacement of 
NaSH with (NH4)2S led to a significant increase in the yield of 
the desired thioacid 7a, although the aminolysis byproduct 9a 
was detected (Table 1, entries 4 and 10, and Fig 1).16 These 
results therefore suggested that (NH4)2S was more suitable for 
the hydrothiolysis of the SEAlide peptide. The phosphate salt 
was also critical for the hydrothiolysis reaction using (NH4)2S as 
the case with the use of NaSH (Table 1, entries 10 and 11). This 
result repeatedly indicated that the existence of phosphate was 
essential for the hydrothiolysis reaction. Melnyk et al.9b recently 
reported the synthesis of peptide thioacids at neutral pH using 
bis(2-sulfanylethyl)amido (SEA) peptides. According to their 
report, the reaction of the model SEA peptide with an excess of 
NaSH at pH 7 in the presence of TCEP and 4-
mercaptophenylacetic acid did not provide direct access to any 
of the peptide thiocarboxylate. The conversion of the SEA 
peptide to the corresponding peptide thioacid therefore required 
the use of triisopropylsilylthiol in the presence of an amino acyl 
thioester, which was used as a scavenger for the resulting SEA 
moiety. In contrast, we successfully obtained the peptide 
thioacid 7a via the hydrothiolysis reaction of SEAlide peptide 6a 
with (NH4)2S under neutral conditions. 
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Table 1. Hydrothiolysis of SEAlide peptide 6a under various reaction conditions. 
 
Entry 
SEAlide 
peptide [mM] 
Na phosphate 
[M] (salt) 
Sulfide 
reagent 
pH 
Reaction time 
[h] 
Yield of 7aa 
[%] 
Yields of  the 
byproductsb 
[%] 
Recovery of 
6ac [%] 
1 1.0 0.0d NaSH 6.9 24 12 9 79 
2 1.0 0.2 NaSH 6.9 24 35 18 48 
3 1.0 0.5 NaSH 6.9 24 39 23 38 
4 1.0 1.0 NaSH 6.9 24 49 20 31 
5e 1.0 1.0 NaSH 6.9 24 43 24 33 
6 2.0 1.0 NaSH 6.9 24 28 27 45 
7 5.0 1.0 NaSH 6.9 24 8 27 65 
8 1.0 1.0 NaSH 5.9 24 6 16 78 
9 1.0 1.0 NaSH 8.3 24 31 49 21 
10 1.0 1.0 (NH4)2S 7.1 24 74 12 14 
11 1.0 0.0d (NH4)2S 7.0 24 18 10 72 
Yield of 7a, yields of the byproducts and recovery of 6a were determined by HPLC separation (detection at 220 nm) using the following calculations (integ. = 
peak area). 
aYield of 7a = integ. 7a/(integ. 6a + integ. 7a + integ. 8a + integ. 9a)×100. 
bYields of the byproducts = (integ. 8a + integ. 9a)/(integ. 6a + integ. 7a + integ. 8a + integ. 9a)×100. 
cRecovery of 6a = integ. 6a/(integ. 6a + integ. 7a + integ. 8a + integ. 9a)×100. 
dHEPES buffer (0.2 M) was employed instead of phosphate buffer. 
eThis reaction was conducted without the addition of NMP. 
 
 
Figure 1. HPLC monitoring of the hydrothiolysis reaction of SEAlide 6a 
with (NH4)2S (Table 1, entry 10) (A) Reaction time = 0 min. (B) Reaction 
time = 24 h. The HPLC conditions are described in the experimental section. 
The asterisked peak indicates a non-peptidyl compound that was derived 
from reaction media. 
 
We then proceeded to investigate the epimerization of the C-
terminal amino acid. Our previous method, which involved a 
hydrogen chloride-induced N-S acyl transfer reaction, was 
accompanied by 20% of the epimerization at the C-terminal 
amino acid residue.4i It was envisaged that the milder reaction 
conditions of our new method would suppress the epimerization 
of the C-terminal residue. Peptide 6b bearing a C-terminal 
alanine residue was converted to the corresponding thioacid 7b 
under the conditions described above in entry 10 of Table 1. 
These conditions resulted in only 2% epimerization, which was 
significantly lower than that observed using hydrogen chloride 
(Fig 2). 
This result encouraged us to examine the effect of different 
C-terminal amino acid residues on the hydrothiolysis reaction 
(Table 2). The C-terminal amino acid was replaced with a series 
of typical amino acids (e.g., Ala, Ser, Lys, Arg, Asn, Leu or Tyr), 
and the resulting peptides were treated with NaSH or (NH4)2S as 
a hydrosulfide source. For peptides 6b–e and 6h (Ala, Ser, Lys, 
Arg or Tyr derivative), the corresponding thioacids 7b–e and 7h 
were successfully formed. Higher yields of the thioacid were 
observed when (NH4)2S was used instead of NaSH (Table 2, 
entries 1–8). Whereas two peaks their mass was identical to the 
7c and its epimer was observed in entry 4 (X = Ser, the major 
peak/the minor peak = 95/5 based on HPLC peak area), the 
minor peak that would be an epimer of 7 was not detected in the 
case of 6b, 6d, 6e and 6h.17 Unfortunately, no peptide thioacid 
was obtained when X was Asn (Table 2, entries 9 and 10). In 
this reaction, the formation of the aspartimide byproduct 1018 
was confirmed by HPLC separation followed by MS analysis 
(Fig 3). When the C-terminal amino acid was Leu, the reaction 
4 
was very slow and gave a complex mixture. In addition, the 
HPLC analysis of this reaction mixture revealed the formation of 
multiple peaks derived from byproducts other than 8g and 9g 
(data not shown). Given that this phenomenon was not observed 
when the C-terminal amino acid was Lys or Arg, it was assumed 
that the presence of a methyl group at the γ-position of Leu was 
having an adverse impact on the rate of the hydrothiolysis 
through steric hindrance, and that the side reactions therefore 
proceeded at a relatively higher rate to generate a complex 
mixture of products. 
 
 
 
Table 2. Hydrothiolysis reactions of the SEAlide peptides containing various amino acids at their C-terminal position 
 
Entry 
SEAlide 
peptide [mM] 
X 
Na Phosphate 
[M] (salt) 
Sulfide reagent pH 
Reaction 
time [h] 
Yield of 7a 
[%] 
Yields of  
the 
byproductsb 
[%] 
Recovery of 
6c [%] 
1 1.0 (6b) Ala 1.0 NaSH 6.9 24 12 39 50 
2 1.0 (6b) Ala 1.0 (NH4)2S 7.0 24 79 3 19 
3 1.0 (6c) Ser 1.0 NaSH 6.9 24 23 20 57 
4 1.0 (6c) Ser 1.0 (NH4)2S 7.2 24 44 8 48 
5 1.0 (6d) Lys 1.0 NaSH 6.9 24 18 5 77 
6 1.0 (6d) Lys 1.0 (NH4)2S 7.1 24 60 <1 40 
7 1.0 (6e) Arg 1.0 NaSH 6.9 24 5 34 62 
8 1.0 (6e) Arg 1.0 (NH4)2S 7.1 24 58 6 36 
9 1.0 (6f) Asn 1.0 NaSH 6.9 24  -d  
10 1.0 (6f) Asn 1.0 (NH4)2S 7.1 24  -d  
11 1.0 (6g) Leu 1.0 (NH4)2S 7.0 76 complex mixture 
12 1.0 (6h) Tyr 1.0 (NH4)2S 6.9 24 33 2 65 
The yield of 7, yields of the byproducts and recovery of 6 were determined by HPLC separation (detection at 220 nm) using the following calculations (integ. = 
peak area). 
aYield of 7 = integ. 7/(integ. 6 + integ. 7 + integ. 8 + integ. 9)×100. 
bYields of the byproducts = (integ. 8 + integ. 9)/(integ. 6 + integ. 7 + integ. 8 + integ. 9)×100. 
cRecovery of 6 = integ. 6/(integ. 6 + integ. 7 + integ. 8 + integ. 9)×100. 
dNot detected. 
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The isolated yields of the peptide thioacids 7a–e were 
estimated and the results are summarized in Table 3. The 
trend in the isolated yields was identical to that of the HPLC-
based yields for 7a–e shown in Tables 1 and 2. The isolated 
yields of the SEAlide peptides with Ala (7b) and Lys (7d) at 
the C-terminus were higher than those of the other peptides 
prepared in this study. These results therefore suggested that 
our newly developed method is practical when the C-terminal 
amino acid was appropriately chosen. 
 
 
Figure 2. HPLC estimation of the epimerization of 7b during the 
hydrothiolysis. (A) Mixture of 7b and its epimer at the C-terminal Ala 
residue (7b’). (B) Crude reaction mixture after the hydrothiolysis of 6b. The 
reaction conditions are shown in entry 2 of Table 2. 
 
 
 
 
Figure 3. Structure of the aspartimide byproduct 10. 
 
 
Table 3. Isolated yields of the peptide thioacids 7a–ea 
Entry 
Peptide 
thioacid 
X 
Isolated yield 
[%] 
1 7a Gly 30 
2 7b Ala 45 
3 7c Ser 10 
4 7d Lys 47 
5 7e Arg 26 
aPeptides 6a–e (1 mM), 120 mM (NH4)2S, 100 mM TCEP·HCl and 250 mM 
sodium ascorbate in 1.0 M sodium phosphate buffer (pH 7), 10% (v/v) NMP, 
37 °C, 24 h. 
3. Conclusion 
An Fmoc SPPS-compatible synthetic protocol for the 
synthesis of C-terminal peptide thioacids from the corresponding 
SEAlide peptides was developed. Characteristic chemical 
behavior of the SEAlide peptide in the presence of phosphate 
salt enabled the facile preparation of thioacids under mild 
conditions.  After the optimization of the reaction conditions, we 
successfully evaluated the scope and limitations of this new 
process. This new method worked well for various C-terminal 
amino acid residues tested in this study (based on the HPLC-
based yields), except for Asn and Leu (Table 2). However, the 
results revealed that the appropriate selection of a C-terminal 
amino acid was critical from a practical perspective in terms of 
the isolated yield (Table 3). 
4. Experimental section 
4.1. General methods 
All of the reactions involving small molecules were carried 
out under a positive pressure of argon at room temperature. 
Purifications by column chromatography were performed over 
silica gel (KANTO KAGAKU N-60). Mass spectra were 
recorded on a Waters MICROMASS® LCT PREMIER™ (ESI-
TOF) or a Bruker Esquire200T (ESI-Ion Trap). NMR spectra 
were measured using a Bruker AV400N at 400 MHz frequency 
for 1H and a JEOL JNM-AL300 at 75 MHz frequency for 13C. 
Purifications by HPLC were performed over a Cosmosil 5C18-
AR-II analytical column (Nacalai Tesque, 4.6 × 250 mm, flow 
rate 1.0 mL/min), a 5C18-AR-II semi-preparative column 
(Nacalai Tesque, 10 × 250 mm, flow rate 3 mL/min) or a 5C18-
AR-II preparative column (Nacalai Tesque, 20 × 250 mm, flow 
rate 10 mL/min) with UV detection at 220 nm. A solvent system 
consisting of 0.1% (v/v) TFA in H2O (solvent A) and 0.1% TFA 
(v/v) in MeCN (solvent B) was used as the mobile phase for the 
HPLC purification processes. The system was eluted with a 
linear gradient of solvent A in solvent B over 30 min according 
to the description provided below unless otherwise noted. 
Optical rotations were measured using a JASCO P-2200 
polarimeter (concentration in g/100 mL). 
4.2. Typical procedure for the preparation of the 4-[(Fmoc-
Xaa){2-(triphenylmethylsulfanyl)ethyl}amino]benzoic acid. 
 
N-Methylaniline (303 µl, 2.79 mmol) and Pd(PPh3)4 (32.3 mg, 
27.9 µmol) were added to a solution of allyl 4-[{Fmoc-
Lys(Boc)}{2-(triphenylmethylsulfanyl)ethyl}amino]benzoate 
11d11b (260 mg, 279 µmol) in THF (6.2 ml), and the resulting 
mixture was stirred overnight. The reaction mixture was 
evaporated to dryness to give a residue, which was treated with 
monohexylamine (32 µL, 28 µmol) and ethyl acetate. The 
resulting mixture was stirred for 5 min and evaporated to 
dryness to give a solid, which was washed with Et2O. The solid 
was partitioned between EtOAc and saturated aqueous citric 
acid, and the organic layer was collected, washed with 5% (w/v) 
aqueous citric acid and dried over MgSO4. The solvent was 
subsequently evaporated under reduced pressure to afford the 
desired product 3d (211 mg) in 85% isolated yield. 
 
4-[{Fmoc-Lys(Boc)}{2-(triphenylmethylsulfanyl)ethyl}amino]-
benzoic acid (3d) 
[α]19D +71.0 (c 1.00, CHCl3); 1H NMR (CDCl3, 400 MHz) δ = 
1.01-1.30 (4H, br m), 1.31-1.52 (2H, m), 1.41 (9H, s), 2.29 (1H, 
m), 2.54 (1H, m), 2.95 (2H, br s), 3.31 (1H, m), 3.60 (1H, m), 
4.12-4.27 (1H, m), 4.19 (1H, t, J = 7.0 Hz), 4.35 (2H, d, J = 7.0 
Hz), 4.54 (1H, s), 5.68 (1H, br d, J = 8.2 Hz), 7.05-7.44 (19H, 
m), 7.39 (2H, t, J = 7.4 Hz), 7.59 (2H, dd, J = 5.6 and 7.7 Hz), 
7.75 (2H, d, J = 7.5 Hz), 8.07 (2H, d, J = 8.3 Hz); 13C NMR 
(CDCl3, 75 MHz) δ = 22.3, 28.5, 29.3, 29.3, 32.6, 40.1, 47.2, 
49.2, 51.6, 67.1, 67.2, 79.3, 120.1, 125.3, 126.8, 127.2, 127.8, 
128.0, 128.4, 129.6, 129.9, 131.9, 141.4, 143.9, 143.9, 144.6, 
145.0, 145.0, 156.2, 168.9, 172.3; HRMS (ESI-TOF) m/z calcd 
for C54H55N3NaO7S ([M+Na]+) 912.3658, found 912.3617. 
4-[{Fmoc-Arg(Pbf)}{2-(triphenylmethylsulfanyl)ethyl}amino]-
benzoic acid (3e) 
Compound 11e was prepared according to the method described 
in reference 11b. 3e, 861 mg, (77%); [α]19D +52.4 (c 1.00, 
6 
CHCl3); 1H NMR (CDCl3, 400 MHz) δ = 1.27-1.35 (2H, m), 
1.38 (3H, s), 1.39 (3H, s), 1.42-1.52 (2H, m), 2.03 (3H, s), 2.22-
2.34 (1H, m), 2.32 (3H, s), 2.38-2.58 (2H, m), 2.52 (3H, s), 
2.71-2.92 (1H, br m), 2.71-2.92 (2H, m), 3.20 (1H, ddd, J = 13.1, 
9.1, 5.7 Hz), 3.73 (1H, br m), 4.16 (1H, t, J = 6.9 Hz), 4.18-4.25 
(2H, m), 4.30-4.40 (2H, m), 5.96 (1H, br d, J = 8.0 Hz), 6.25 
(2H, br s), 7.06 (2H, d, J = 8.0 Hz), 7.09-7.44 (20H, m), 7.54 
(1H, d, J = 7.4 Hz), 7.58 (1H, d, J = 7.4 Hz ), 7.75 (2H, d, J = 
7.5 Hz), 8.02 (2H, d, J = 8.0 Hz); 13C NMR (CDCl3, 75 MHz) δ 
= 12.6, 17.9, 19.4, 24.7, 28.7, 29.2, 30.8, 40.1, 43.3, 47.2, 49.1, 
50.7, 67.2, 67.5, 86.5, 117.6, 120.2, 120.2, 124.8, 125.2, 126.9, 
127.3, 127.9, 128.0, 128.4, 129.6, 130.5, 131.9, 132.6, 138.7, 
141.4, 143.6, 143.7, 144.4, 144.5, 156.7, 156.8, 158.9, 168.5, 
171.4; HRMS (ESI-TOF) m/z calcd for C62H63N5O8S2 ([M+H]+) 
1070.4196, found 1070.4196. 
4-[(Fmoc-Leu){2-(triphenylmethylsulfanyl)ethyl}amino]benzoic 
acid (3g) 
Compound 11g was prepared according to the method described 
in reference 11b. 3g, 1.27 g, (77%); [α]19D +95.3 (c 1.00, 
CHCl3); 1H NMR (CDCl3, 400 MHz) δ = 0.37 (3H, d, J = 6.0 
Hz), 0.72 (3H, d, J = 6.1 Hz), 1.09-1.20 (1H, m), 1.34-1.51 (2H, 
m), 2.27-2.35 (1H, m), 2.49-2.60 (1H, m), 3.24-3.35 (1H, m), 
3.57-3.68 (1H, m), 4.20 (1H, t, J = 7.1 Hz), 4.23-4.39 (3H, m), 
5.50 (1H, d, J = 9.1 Hz), 7.10-7.36 (19H, m), 7.39 (2H, t, J = 7.4 
Hz), 7.59 (1H, d, J = 7.2 Hz), 7.60 (1H, d, J = 7.2 Hz), 7.76 (2H, 
d, J = 7.5 Hz), 8.11 (2H, d, J = 8.1 Hz); 13C NMR (CDCl3, 75 
MHz) δ =20.9, 23.4, 24.5, 29.4, 42.3, 47.3, 49.2, 50.5, 67.2, 
120.1, 125.3, 126.8, 127.2, 127.8, 128.0, 128.6, 129.3, 129.7, 
131.9, 141.5, 143.9, 144.0, 144.7, 145.5, 156.4, 169.4, 172.9; 
HRMS (ESI-TOF) m/z calcd for C49H46N2NaO5S ([M+Na]+) 
797.3025, found 797.3036. 
 
4.3. General procedure for the preparation of SEAlide peptides 
6 
NovaSyn TGR resin (Rink amide type: 0.22 mmol amine/g, 
0.46 g, 0.10 mmol) was coupled with Fmoc-Leu-OH (106 mg, 
0.30 mmol) using HBTU (110 mg, 0.29 mmol) and DIPEA (52 
µL, 0.30 mmol) in DMF at room temperature for 0.5 h. The 
subsequent removal of the Fmoc group with 20% (v/v) 
piperidine in DMF gave the corresponding Leu-incorporated 
resin. This material was then treated with a mixture of 3 (0.20 
mmol, preparation of 3a–c, 3f and 3h are described in reference 
4i, 11b and 19), HATU (72 mg, 0.19 mmol) and DIPEA (32 µl, 
0.20 mmol) in DMF at room temperature for 2 h to yield the 
Fmoc-aminoacyl SEAlide-incorporated resin 4. This resin was 
subjected to a standard Fmoc SPPS (coupling: Fmoc amino 
acid/HBTU/DIEPA (3.0/2.9/3.0 equiv), 0.5 h; Fmoc removal: 
20% (v/v) piperidine in DMF, 10 min) for the elongation of the 
peptide chain to give the protected peptide resin 5. The 
completed resin (30 or 200 mg) was exposed to a TFA-based 
mixture of reagents (i.e., TFA/thioanisole/m-cresol/EDT/H2O – 
82:5:5:3:5 (v/v), 50 µL/1 mg of the resin) at room temperature 
for 120–150 min. The reaction mixture was filtered and treated 
with cold Et2O to afford a precipitate, which was collected by 
centrifugation and purified by reversed-phase preparative HPLC 
to give SEAlide peptide 6. 
6a, 15.6 mg (25% as 6a·2TFA); Analytical HPLC conditions: 
20-40%, retention time = 24.8 min; LRMS (ESI-Ion Trap) m/z 
calcd. for [M+H]+ 1628.8, found 1628.2. 
6b, 22.9 mg (36% as 6b·2TFA); Analytical HPLC conditions: 
20-40%, retention time = 25.6 min; LRMS (ESI-Ion Trap) m/z 
calcd. for [M+H]+ 1642.8, found 1643.1. 
6c, 21.4 mg (34% as 6c·2TFA); Analytical HPLC conditions: 
20-40%, retention time = 23.4 min; LRMS (ESI-Ion Trap) m/z 
calcd. for [M+H]+ 1658.8, found 1659.0. 
6d, 13.6 mg (18% as 6d·3TFA); Analytical HPLC conditions: 
20-40%, retention time = 22.7 min; LRMS (ESI-Ion Trap) m/z 
calcd. for [M+H]+ 1699.8, found 1700.3. 
6e, 19.4 mg (22% as 6e·3TFA); Analytical HPLC conditions: 
20-40%, retention time = 23.2 min; LRMS (ESI-TOF) m/z calcd. 
for [M+H]+ 1727.8, found 1727.9. 
6f, 0.5 mg (5% as 6f·2TFA); Analytical HPLC conditions: 20-
40%, retention time = 22.1 min; LRMS (ESI-Ion Trap) m/z calcd. 
for [M+H]+ 1685.8, found 1686.1. 
6g, 17.3 mg (33% as 6g·2TFA); Analytical HPLC conditions: 
20-50%, retention time = 23.0 min; LRMS (ESI-TOF) m/z calcd. 
for [M+2H]2+ 842.9, found 842.7. 
6h, 20.9 mg (32% as 6h·2TFA); Analytical HPLC conditions: 
20-50%, retention time = 21.4 min; LRMS (ESI-TOF) m/z calcd. 
for [M+2H]2+ 867.9, found 867.6. 
 
4.4. General procedure for preparation of C-terminal peptide 
thioacids 7a-h 
To a solution of the SEAlide peptide 6 (1.0 µmol) in NMP 
(100 µL) were added 1.0 M Na phosphate buffer (900 µL) 
containing 120 mM NaSH or (NH4)2S, 100 mM TCEP·HCl and 
250 mM Na ascorbate, and the resulting mixture was incubated 
at 37 °C. Five-microliter aliquots of the reaction mixture were 
collected at regular time intervals and analyzed by analytical 
HPLC. To determine the isolated yields, we fractionated an 
entire reaction mixture by semi-preparative HPLC following 24 
h of the reaction and the product was obtained after 
lyophilization. 
7a. Analytical HPLC conditions: 20-40%, retention time = 20.3 
min; LRMS (ESI-TOF) m/z calcd. for [M+2H]2+ 677.3, found 
677.3. 
8a. Analytical HPLC conditions: 20-40%, retention time = 16.7 
min; LRMS (ESI-TOF) m/z calcd. for [M+2H]2+ 669.3, found 
669.3. 
9a. Analytical HPLC conditions: 20-40%, retention time = 15.8 
min; LRMS (ESI-TOF) m/z calcd. for [M+2H]2+ 668.8, found 
668.8. 
Thioester of 6a. Analytical HPLC conditions: 20-40%, retention 
time = 25.6 min; LRMS (ESI-TOF) m/z calcd. for [M+2H]2+ 
814.9, found 814.9. 
SEAlide deriv. Analytical HPLC conditions: 20-40%, retention 
time = 21.7 min; LRMS (ESI-TOF) m/z calcd. for [M+H]+ 310.2, 
found 310.4. 
7b. Analytical HPLC conditions: 20-40%, retention time = 21.3 
min; LRMS (ESI-TOF) m/z calcd. for [M+2H]2+ 684.3, found 
684.2. 
8b. Analytical HPLC conditions: 20-40%, retention time = 16.8 
min; LRMS (ESI-TOF) m/z calcd. for [M+2H]2+ 676.3, found 
676.2.  
9b. Analytical HPLC conditions: 20-40%, retention time = 15.8 
min; LRMS (ESI-TOF) m/z calcd. for [M+2H]2+ 675.8, found 
675.8.  
7c. Analytical HPLC conditions: 20-40%, retention time = 19.0 
min; LRMS (ESI-TOF) m/z calcd. for [M+2H]2+ 692.3, found 
692.5. 
8c. Analytical HPLC conditions: 20-40%, retention time = 16.1 
min; LRMS (ESI-TOF) m/z calcd. for[M+2H]2+ 684.3, found 
684.5. 
9c. Analytical HPLC conditions: 20-40%, retention time = 15.2 
min; LRMS (ESI-TOF) m/z calcd. for [M+2H]2+ 683.8, found 
683.9. 
7d. Analytical HPLC conditions: 20-40%, retention time = 16.0 
min; LRMS (ESI-TOF) m/z calcd. for [M+2H]2+ 712.9, found 
712.8. 
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8d. Analytical HPLC conditions: 20-40%, retention time = 13.0 
min; LRMS (ESI-TOF) m/z calcd. for [M+2H]2+ 704.9, found 
704.8 
9d. Analytical HPLC conditions: 20-40%, retention time = 12.1 
min; LRMS (ESI-Ion Trap) m/z calcd. for [M+2H]2+ 704.4, 
found 704.6. 
7e. Analytical HPLC conditions: 20-40%, retention time = 16.3 
min; LRMS (ESI-TOF) m/z calcd. for [M+2H]2+ 726.8, found 
726.7. 
8e. Analytical HPLC conditions: 20-40%, retention time = 13.5 
min; LRMS (ESI-TOF) m/z calcd. for [M+2H]2+ 718.9, found 
718.8. 
9e. Analytical HPLC conditions: 20-40%, retention time = 12.7 
min; LRMS (ESI-TOF) m/z calcd. for [M+2H]2+ 718.4, found 
718.4. 
7g. Analytical HPLC conditions: 15-45%, retention time = 26.6 
min; LRMS (ESI-TOF) m/z calcd. for [M+2H]2+ 705.3, found 
705.2. 
8g. Analytical HPLC conditions: 15-45%, retention time = 23.0 
min; LRMS (ESI-TOF) m/z calcd. for [M+2H]2+ 697.3, found 
697.3. 
9g. Analytical HPLC conditions: 15-45%, retention time = 22.2 
min; LRMS (ESI-TOF) m/z calcd. for [M+2H]2+ 696.9, found 
696.8. 
7h. Analytical HPLC conditions: 20-50%, retention time = 17.4 
min; LRMS (ESI-TOF) m/z calcd. for [M+2H]2+ 730.3, found 
730.2. 
8h. Analytical HPLC conditions: 20-50%, retention time = 14.6 
min; LRMS (ESI-TOF) m/z calcd. for [M+2H]2+ 722.3, found 
722.3. 
9h. Analytical HPLC conditions: 20-50%, retention time = 13.6 
min; LRMS (ESI-TOF) m/z calcd. for [M+2H]2+ 721.8, found 
721.8. 
10. Analytical HPLC conditions: 20-40%, retention time = 15.8 
min; LRMS (ESI-TOF) m/z calcd. for [M+2H]2+ 688.8, found 
688.8. 
 
4.5. Examination of the C-terminal epimerization 
Analyte 7b was prepared using the protocol described above 
and analyzed by HPLC using two analytical columns, which 
were connected in sequence. The analytical HPLC conditions 
were as follows: 22%–32% over 120 min, retention times = 74.3 
min (7b) and 72.7 min (7b’: epimer of 7b at the C-terminal Ala 
residue). 
 
The epimer of 7b at the C-terminal Ala residue was prepared 
as follows. Peptide thioester 12 was prepared via a Boc SPPS 
method using an in situ neutralization protocol20 on 
HSCH2CH2CO-Leu-MBHA resin (0.70 mmol amine/g, 0.14 g, 
0.10 mmol). The resulting resin was treated with a mixture of 
1.0 M TMSOTf/thioanisole (50 µL/1 mg resin), m-cresol and 
EDT (100:5:5 (v/v)) at 0 °C for 2 h. The reaction mixture was 
filtered and treated with cold Et2O to afford a precipitate, which 
was collected by centrifugation and dissolved in a mixture of 
0.1% (v/v) TFA in H2O and 0.1% TFA (v/v) in MeCN (5 mL, 
1:1 (v/v)). The resulting solution was lyophilized to give crude 
12, which was dissolved in 5 mL of 1.0 M sodium phosphate 
containing 120 mM NaSH (pH 9.1). The resulting solution was 
held at room temperature for 1 h before being fractionated by 
preparative HPLC to give pure 7b’ after lyophilization. 
Analytical HPLC conditions: 20-40%, retention time = 22.7 
min; LRMS (ESI-Ion Trap) m/z calcd. for [M+H]+ 1367.6, found 
1368.0. 
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